category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-5807,0.012005812201580373,0.9999492904296446,1,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-2582,0.016460374848536682,0.9998955805423511,1,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-282,0.02055165049041412,0.9998369371622209,1,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-5791,0.021783542785302163,0.9998138181051881,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5837,0.021783542785302163,0.9998138181051881,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWY-6544,0.021880785820133267,0.9998079071156725,1,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-699,0.021880785820133267,0.9998079071156725,1,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-5136,0.027897138892072876,0.9996803231338035,1,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWY-7204,0.03386106910909731,0.9995233902062282,1,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:CHLOROPHYLL-SYN,0.0464810804624402,0.9990811283870767,1,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:PWY-5884,0.0583982741397824,0.9985424995036066,1,22,wax esters biosynthesis I,BioCyc
ARA:PWY-6733,0.08977178077329681,0.9964408698080989,1,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-6842,0.1996605720361739,0.9813446217039805,1,71,glutathione-mediated detoxification II,BioCyc
ARA:PHOTOALL-PWY,0.9999999999999993,0.7838657670831785,0,85,oxygenic photosynthesis,BioCyc
ARA:PWY-5083,0.9999999999999996,0.8000366126620164,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:ALACAT2-PWY,1,0.9757600346700752,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.9832134691505794,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.9832134691505794,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.9918477456265847,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.9943722275746832,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.994494632972941,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.9889257641626128,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.9740285373532428,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.9656528970789224,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.9674711738674201,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.9890467517577135,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINE-DEG1-PWY,1,0.9866959887537678,0,6,L-asparagine degradation I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.9890467517577135,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.9744915501557451,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.9744915501557451,0,14,L-aspartate biosynthesis,BioCyc
ARA:ASPASN-ARA-PWY,1,0.9509022201677629,0,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:ASPSYNII-PWY,1,0.9814311411673997,0,10,cyanide detoxification I,BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,1,0.9288407572146049,0,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.9721667616546907,0,12,spermidine biosynthesis I,BioCyc
ARA:CALVIN-PWY,1,0.914003978788782,0,39,Calvin-Benson-Bassham cycle,BioCyc
ARA:CAMALEXIN-SYN,1,0.9399654434422229,0,29,camalexin biosynthesis,BioCyc
ARA:CITRULBIO-PWY,1,0.9320281744224248,0,35,L-citrulline biosynthesis,BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.9980169416478081,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.9763799899949002,0,9,coenzyme A biosynthesis I,BioCyc
ARA:CYANCAT-PWY,1,0.9931699046676519,0,3,cyanate degradation,BioCyc
ARA:CYSTSYN-PWY,1,0.948236626035822,0,25,L-cysteine biosynthesis I,BioCyc
ARA:DETOX1-PWY,1,0.9587552886010927,0,21,superoxide radicals degradation,BioCyc
ARA:DETOX1-PWY-1,1,0.9403604318659345,0,28,reactive oxygen species degradation,BioCyc
ARA:ETHYL-PWY,1,0.940392870119514,0,31,ethylene biosynthesis I (plants),BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,1,0.9771503948588584,0,12,ethanol degradation I,BioCyc
ARA:FASYN-ELONG-PWY,1,0.9616612577790257,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.9815771254445738,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCONEO-PWY,1,0.8858758169369392,0,60,gluconeogenesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.9626071825180117,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9962019250044047,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.9930119834200655,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.9924352862175758,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.9924352862175758,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTAMINDEG-PWY,1,0.9443742071791442,0,28,L-glutamine degradation I,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9945765373814581,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.9747297051295322,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.9891771418864557,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCLEAV-PWY,1,0.9626254329008268,0,17,glycine cleavage,BioCyc
ARA:GLYCOLYSIS,1,0.892763535800206,0,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:GLYOXDEG-PWY,1,0.9964727900492383,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYOXYLATE-BYPASS,1,0.9648890832521296,0,17,glyoxylate cycle,BioCyc
ARA:GLYSYN-ALA-PWY,1,0.9779184139130092,0,12,glycine biosynthesis III,BioCyc
ARA:GLYSYN-PWY,1,0.9788231340087166,0,11,glycine biosynthesis I,BioCyc
ARA:GLYSYN2-PWY,1,0.9625363192481338,0,20,glycine biosynthesis,BioCyc
ARA:HEME-BIOSYNTHESIS-II,1,0.9741484209744774,0,14,heme biosynthesis I (aerobic),BioCyc
ARA:HEXPPSYN-PWY,1,0.9962742007576082,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HISTSYN-PWY,1,0.969778563228085,0,16,L-histidine biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.9981377162284885,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.9877378826950717,0,4,L-threonine biosynthesis,BioCyc
ARA:HOMOSERSYN-PWY,1,0.9822311298112993,0,10,L-homoserine biosynthesis,BioCyc
ARA:ILE-VAL-PWY,1,0.9657669459797251,0,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:ILEUDEG-PWY,1,0.9594576576538864,0,20,L-isoleucine degradation I,BioCyc
ARA:ILEUSYN-PWY,1,0.9781553608537255,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.996326471592743,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9978557400334241,0,1,L-cysteine degradation II,BioCyc
ARA:LEU-DEG2-PWY,1,0.9381269169831848,0,32,L-leucine degradation I,BioCyc
ARA:LEUSYN-PWY,1,0.9460616415637633,0,27,L-leucine biosynthesis,BioCyc
ARA:LIPAS-PWY,1,0.8270555605469428,0,93,triacylglycerol degradation,BioCyc
ARA:LIPASYN-PWY,1,0.8654323905328176,0,72,phospholipases,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.9785936171264012,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.960416023531591,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.9921496194532695,0,4,D-mannose degradation,BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,1,0.9461917080099669,0,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.9820862902437133,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.9776182051729915,0,11,lipid IVA biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,1,0.9677908843648283,0,15,methylerythritol phosphate pathway I,BioCyc
ARA:NONOXIPENT-PWY,1,0.9631007205861596,0,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:OXIDATIVEPENT-PWY,1,0.9570816963685617,0,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:P401-PWY,1,0.983242272008319,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.9866434245123493,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PENTOSE-P-PWY,1,0.9215751041488757,0,36,pentose phosphate pathway,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.9888225815242222,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PLPSAL-PWY,1,0.9897104026226434,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.9944490022948556,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9939767208054193,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.9926975183954064,0,4,L-proline degradation,BioCyc
ARA:PWY-1001,1,0.9652557928421154,0,20,cellulose biosynthesis,BioCyc
ARA:PWY-101,1,0.8591045762689069,0,46,photosynthesis light reactions,BioCyc
ARA:PWY-102,1,0.9815339192171669,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1042,1,0.8967631763021225,0,55,glycolysis IV (plant cytosol),BioCyc
ARA:PWY-1061,1,0.9428255429248549,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-1081,1,0.9278009458352493,0,38,homogalacturonan degradation,BioCyc
ARA:PWY-112,1,0.9878126318616831,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-1121,1,0.8830452584938792,0,54,suberin monomers biosynthesis,BioCyc
ARA:PWY-116,1,0.9915806906369796,0,4,coniferin metabolism,BioCyc
ARA:PWY-1186,1,0.9850486681685812,0,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-1187,1,0.9230180893736533,0,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-1269,1,0.9827196944029514,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1422,1,0.9802163829148123,0,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-1581,1,0.9858811231691305,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.9835419065407811,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1782,1,0.970702842110891,0,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:PWY-1801,1,0.9962248109661986,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-181,1,0.9252556506273606,0,36,photorespiration,BioCyc
ARA:PWY-1822,1,0.9862447350208595,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.9981618790265887,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.994537191094772,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2021,1,0.9815475465298111,0,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-2161,1,0.9701661076464376,0,16,folate polyglutamylation,BioCyc
ARA:PWY-2161B,1,0.9889355045836801,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.9820092089390724,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2181,1,0.9892336409916156,0,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:PWY-2261,1,0.93847234463765306,0,26,ascorbate glutathione cycle,BioCyc
ARA:PWY-2301,1,0.988837632867391,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2501,1,0.972885112395883,0,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-2541,1,0.9154874148307267,0,44,plant sterol biosynthesis,BioCyc
ARA:PWY-2602,1,0.9960528071618446,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.9639221429111924,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2724,1,0.9782728075525249,0,12,alkane oxidation,BioCyc
ARA:PWY-2781,1,0.9963301464654336,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-2821,1,0.9576164232337411,0,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-2841,1,0.9871736029859811,0,7,cytokinins degradation,BioCyc
ARA:PWY-2881,1,0.9851708373660081,0,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,1,0.9851708373660081,0,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-2902,1,0.9832203229808846,0,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-3001,1,0.9228094567376486,0,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY-3041,1,0.991757355599436,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3101,1,0.9748743477224521,0,11,flavonol biosynthesis,BioCyc
ARA:PWY-3181,1,0.991833982392835,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-321,1,0.9193838380199386,0,35,cutin biosynthesis,BioCyc
ARA:PWY-3221,1,0.9977847825396511,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.9922900322850147,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.9262400289099734,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.9921499271379072,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.973917741934954,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.9820219938767423,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.9738403168558704,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.967801307785437,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3561,1,0.9551962122911448,0,26,choline biosynthesis III,BioCyc
ARA:PWY-361,1,0.8940879155687133,0,54,phenylpropanoid biosynthesis,BioCyc
ARA:PWY-3742,1,0.9363431709762722,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3781,1,0.7246890349211487,0,104,aerobic respiration I (cytochrome c),BioCyc
ARA:PWY-3801,1,0.9220200365154624,0,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-381,1,0.9761645342137458,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.9847360255810433,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3841,1,0.926996045028821,0,38,folate transformations II,BioCyc
ARA:PWY-3881,1,0.9861978491711181,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3941,1,0.9883229475245697,0,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-3982,1,0.9943031581345749,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9946004599817012,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.994494632972941,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-401,1,0.9835441918526677,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-4041,1,0.9739794321164943,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.965617055060837,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4101,1,0.9615752207999122,0,17,D-sorbitol degradation I,BioCyc
ARA:PWY-4203,1,0.9936919477265228,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.9633001045794795,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.996324549725117,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.9888644784656879,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4302,1,0.7666756009455339,0,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:PWY-4321,1,0.9777140443977154,0,12,L-glutamate degradation IV,BioCyc
ARA:PWY-4341,1,0.9974682811257305,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4361,1,0.959493101948014,0,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-4381,1,0.9740051909311831,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.9807576289646932,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.9693103078125471,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.9730481822182055,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.9924879190660112,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.9693103078125471,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.9593927215222312,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.986204923668814,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.9872613222448577,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.990760330962508,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.9887307822280995,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.9907486945271903,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9982001637422235,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.992641315743265,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5035,1,0.9700662079375475,0,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5036,1,0.9953650635613503,0,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-5041,1,0.9716484620064206,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.9691397718146129,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5046,1,0.9648265389941227,0,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-5049,1,0.9974545405860584,0,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-5060,1,0.9917767989405095,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5063,1,0.998083763742984,0,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-5064,1,0.9962494131684168,0,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-5068,1,0.9890654184515814,0,6,chlorophyll cycle,BioCyc
ARA:PWY-5070,1,0.9794031514771324,0,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:PWY-5079,1,0.985113706775027,0,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-5080,1,0.9178639644272577,0,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:PWY-5084,1,0.968660822079965,0,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:PWY-5086,1,0.9981625679980162,0,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5097,1,0.9650707281334833,0,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-5098,1,0.9857033993946542,0,7,chlorophyll a degradation I,BioCyc
ARA:PWY-5107,1,0.995949194225394,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.9853280666161006,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9963263892328147,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.9205333038867229,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.998161904092698,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5120,1,0.9598167220018106,0,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5121,1,0.9200936378123595,0,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5122,1,0.9567134527623992,0,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5123,1,0.9479631661716342,0,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
ARA:PWY-5125,1,0.9826889008484276,0,8,anthocyanin biosynthesis,BioCyc
ARA:PWY-5129,1,0.9381117695425112,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5138,1,0.9755775749999661,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.9881576740768213,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5143,1,0.9644403670060722,0,17,long-chain fatty acid activation,BioCyc
ARA:PWY-5147,1,0.9403053134369364,0,30,oleate biosynthesis I (plants),BioCyc
ARA:PWY-5148,1,0.9732637997467015,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5152,1,0.9773334871829501,0,10,leucodelphinidin biosynthesis,BioCyc
ARA:PWY-5168,1,0.9922584427642088,0,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY-5172,1,0.9854524560822281,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9981619357161206,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.9981668911715792,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.9753401677589238,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5194,1,0.9898242867297015,0,5,siroheme biosynthesis,BioCyc
ARA:PWY-5203,1,0.9796130075668361,0,9,soybean saponin I biosynthesis,BioCyc
ARA:PWY-5267,1,0.9821471724112855,0,9,glucosinolate activation,BioCyc
ARA:PWY-5269,1,0.9870008611319271,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5271,1,0.9963081423084091,0,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-5272,1,0.9785319042064831,0,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-5285,1,0.9959817399812433,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.997976094672275,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5313,1,0.9905355743599096,0,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-5320,1,0.9654260496067867,0,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5321,1,0.8999213541151623,0,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5326,1,0.9960679299634935,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5337,1,0.9759382316461561,0,12,stachyose biosynthesis,BioCyc
ARA:PWY-5340,1,0.9784969845933843,0,10,sulfate activation for sulfonation,BioCyc
ARA:PWY-5342,1,0.9981825608968186,0,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-5343,1,0.9981622024114207,0,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:PWY-5350,1,0.9702173360717546,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.9881576740768213,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.9895500165975221,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5381,1,0.9073904087874418,0,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-5386,1,0.9592810666807218,0,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5389,1,0.9921401231162976,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5391,1,0.979340077902357,0,9,syringetin biosynthesis,BioCyc
ARA:PWY-5410,1,0.9814913435547034,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5441,1,0.9910523493635088,0,5,S-methyl-L-methionine cycle,BioCyc
ARA:PWY-5453,1,0.9652069542633469,0,13,methylglyoxal degradation III,BioCyc
ARA:PWY-5466,1,0.9940369199334185,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.9951471824975727,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.9973473143528,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5484,1,0.8813180775265661,0,63,glycolysis II (from fructose 6-phosphate),BioCyc
ARA:PWY-5486,1,0.9698441787560003,0,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-5530,1,0.9841762069529774,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.9277570967430506,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5640,1,0.9973093033664971,0,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5659,1,0.9624321916831996,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5661,1,0.9715307927954278,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY-5667,1,0.954253865388212,0,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:PWY-5669,1,0.9910420822681297,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5670,1,0.9872167691340534,0,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY-5686,1,0.9889865176941386,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5687,1,0.922150760810622,0,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-5690,1,0.9100830169794786,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.9927304799432795,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.9963271829040524,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.9963284547114998,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.9926694634253578,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.9982514068164073,0,1,urea degradation II,BioCyc
ARA:PWY-5723,1,0.9126616551946507,0,41,Rubisco shunt,BioCyc
ARA:PWY-5765,1,0.9921686533666481,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9962742007576082,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5788,1,0.9815475465298111,0,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-5800,1,0.9729479670618878,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9962742007576082,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-581,1,0.9387313411157007,0,31,indole-3-acetate biosynthesis II,BioCyc
ARA:PWY-5859,1,0.9708674803441067,0,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:PWY-5868,1,0.9425686777903086,0,28,simple coumarins biosynthesis,BioCyc
ARA:PWY-5871,1,0.9854468387027251,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.9962529972690466,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5886,1,0.992562675282759,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.9921956005653204,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.9792056736998023,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5934,1,0.9715378008210169,0,14,iron reduction and absorption,BioCyc
ARA:PWY-5936,1,0.9475631013848728,0,26,xyloglucan biosynthesis,BioCyc
ARA:PWY-5943,1,0.997848093235932,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.9980315593817475,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.9922677080141012,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9981619357161206,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5947,1,0.9926243490970129,0,4,lutein biosynthesis,BioCyc
ARA:PWY-5957,1,0.9900602050810036,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.9795685625940561,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5971,1,0.9065748114095593,0,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5973,1,0.940264575377128,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5980,1,0.936305601763192,0,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY-5986,1,0.9958070332195891,0,2,ammonium transport,BioCyc
ARA:PWY-5989,1,0.9099554457319939,0,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5992,1,0.9163050066382097,0,42,thalianol and derivatives biosynthesis,BioCyc
ARA:PWY-5995,1,0.9942705872108147,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.9944801018469956,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.9952830797198325,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.9963917048671626,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.9982468830957908,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.9968054075896545,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.9336749307121168,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.9917823537305986,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6014,1,0.9891157569895075,0,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6019,1,0.9923827617150618,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6039,1,0.9541888825422045,0,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY-6040,1,0.97350576126522,0,12,chlorogenic acid biosynthesis II,BioCyc
ARA:PWY-6051,1,0.9829791998010547,0,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:PWY-6064,1,0.9957766388015876,0,2,methylquercetin biosynthesis,BioCyc
ARA:PWY-6066,1,0.9962754890124009,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.9811850509044086,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.9852778026480712,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.9865838541053256,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.9865838541053256,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6124,1,0.9891079397150729,0,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9965658839244981,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6137,1,0.9892395317190327,0,6,copper transport II,BioCyc
ARA:PWY-6147,1,0.982247024491235,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6163,1,0.9832281365203053,0,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-6164,1,0.990749969497119,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.9956282944166366,0,2,D-serine metabolism,BioCyc
ARA:PWY-6199,1,0.9765060171976467,0,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-621,1,0.9415382190247744,0,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:PWY-6213,1,0.9902844984438961,0,6,cadmium transport I,BioCyc
ARA:PWY-6219,1,0.9815475465298111,0,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-622,1,0.9430789270909148,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.9908548439253241,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6232,1,0.9976274702838461,0,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-6233,1,0.9908548439253241,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.9912160913621701,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6239,1,0.9980468607149799,0,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-6266,1,0.8999213541151623,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,1,0.8999213541151623,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6287,1,0.987430100918936,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.9942120118871616,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.9797014460678032,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6303,1,0.9904808955696333,0,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-6304,1,0.9924677036653101,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.9925012898030695,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.9731811649975205,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6333,1,0.9771503948588584,0,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-6348,1,0.9396687073426262,0,27,phosphate acquisition,BioCyc
ARA:PWY-6351,1,0.9059630794259851,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6352,1,0.8972031598638497,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6363,1,0.9633055175797398,0,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:PWY-6364,1,0.9791176301823207,0,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6367,1,0.9721369615933779,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.9876220539217695,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-6406,1,0.9963632308538948,0,2,salicylate biosynthesis I,BioCyc
ARA:PWY-641,1,0.9920877308017323,0,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-6424,1,0.9948020844753163,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.9785841872547243,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.9872661096357515,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6443,1,0.8762293118927279,0,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:PWY-6444,1,0.9729030855240403,0,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6446,1,0.9628723461202615,0,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6457,1,0.9843003786988902,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6466,1,0.9816515698483588,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6473,1,0.9946610994166251,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.9757989547290565,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.9818566611775439,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.9826576418932036,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.9950578772866643,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.9926158092754342,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.976051841138598,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.9946610994166251,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.9889063697419793,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6545,1,0.9312541218315692,0,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-6546,1,0.9768186584526265,0,9,brassinosteroids inactivation,BioCyc
ARA:PWY-6549,1,0.9315077205210416,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.9693103078125471,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.9907688653793579,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.9944598713977449,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.9591457525369851,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.9935125855304966,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.9832040928884068,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.9754877680044095,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.9706217505160721,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6607,1,0.9728808630807597,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-6612,1,0.9713260397883116,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.9832552831268925,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.9853707483569641,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.9963293046294498,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.9933313875170849,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6624,1,0.9949621113836752,0,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6663,1,0.964889102615661,0,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-6666,1,0.9956730570482982,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6673,1,0.9822634549391045,0,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6707,1,0.9981673728802827,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6710,1,0.9891157569895075,0,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:PWY-6724,1,0.9725656487700569,0,15,starch degradation II,BioCyc
ARA:PWY-6730,1,0.9902460685701798,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6736,1,0.994145920380922,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.9850372561834575,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6754,1,0.9815403199817855,0,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-6756,1,0.9874134312407549,0,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PWY-6762,1,0.9949621113836752,0,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-6773,1,0.9766523653412347,0,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:PWY-6786,1,0.9621531550843768,0,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:PWY-6787,1,0.938217000014992,0,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-6792,1,0.9737177183864645,0,10,scopoletin biosynthesis,BioCyc
ARA:PWY-6799,1,0.9963283541517562,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.9963017326914303,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6803,1,0.8726617958612309,0,65,phosphatidylcholine acyl editing,BioCyc
ARA:PWY-6804,1,0.9898343631606821,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9944098767316414,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6823,1,0.9507785539258335,0,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-6825,1,0.9777774892495832,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.9705883080909947,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6845,1,0.9944286802128544,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6890,1,0.9963277769612826,0,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY-6898,1,0.9805352577841412,0,8,thiamine salvage III,BioCyc
ARA:PWY-6902,1,0.9558030814240942,0,15,chitin degradation II (Vibrio),BioCyc
ARA:PWY-6908,1,0.9733895639196224,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9976522069967714,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.9981615367958112,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.9856237477033777,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6927,1,0.9727346864982008,0,14,chlorophyll a degradation II,BioCyc
ARA:PWY-6930,1,0.9903531078277227,0,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-6931,1,0.9985018900646513,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6932,1,0.996252656180999,0,2,selenate reduction,BioCyc
ARA:PWY-6936,1,0.9787959748508718,0,10,seleno-amino acid biosynthesis,BioCyc
ARA:PWY-6938,1,0.9963135984184628,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.9741979218557537,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.9668345795304016,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.9694795746496662,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.977840353663837,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6964,1,0.9790862668095838,0,12,ammonia assimilation cycle II,BioCyc
ARA:PWY-6982,1,0.9724064630761388,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-701,1,0.9978335563134701,0,1,L-methionine degradation II,BioCyc
ARA:PWY-702,1,0.9630024429142956,0,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-7036,1,0.9423903068309456,0,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-7039,1,0.9047575156260038,0,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7047,1,0.9856023228426517,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.9892527254614156,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.9869685722393875,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.990179429752592,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.9868114020939422,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.9868114020939422,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9945203051840816,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.9928656228110291,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.9878606367721896,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9942329694814858,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.995911446776362,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.9960050858975531,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7176,1,0.9385025739748113,0,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY-7177,1,0.9680497429061442,0,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWY-7183,1,0.9802441421213188,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7184,1,0.9209405406321212,0,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7185,1,0.9482132256368568,0,29,UTP and CTP dephosphorylation I,BioCyc
ARA:PWY-7186,1,0.9691615540944079,0,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:PWY-7187,1,0.9429741827277003,0,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-7193,1,0.9679413838251871,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7196,1,0.9047055099102111,0,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWY-7197,1,0.9622302540022271,0,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:PWY-7199,1,0.9736624251579789,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7200,1,0.936766641066719,0,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-7205,1,0.9627319916054355,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.977951977540138,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7208,1,0.9198152360617912,0,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-7211,1,0.8749158661027706,0,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7213,1,0.9867546917774304,0,7,wogonin metabolism,BioCyc
ARA:PWY-7219,1,0.889558885768602,0,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7221,1,0.9581771781895816,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.9657012965428935,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.9706614404120937,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.9706614404120937,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.9318202939507597,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-724,1,0.9220483955713885,0,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-7250,1,0.9979318176061749,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7267,1,0.9905355743599096,0,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-7270,1,0.9190285934340782,0,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-7325,1,0.9980871996123637,0,1,salvigenin biosynthesis,BioCyc
ARA:PWY-7343,1,0.9754078189091558,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.988922543052543,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.9905493692568076,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.9512740557718726,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.9674083792122807,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.9360136146886957,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7398,1,0.9564931727087452,0,19,coumarins biosynthesis (engineered),BioCyc
ARA:PWY-7416,1,0.9462925599657344,0,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:PWY-7432,1,0.97663134454338,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7436,1,0.9931770374072999,0,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-7450,1,0.9430139022844398,0,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:PWY-7468,1,0.9949621113836752,0,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:PWY-7528,1,0.9406191349031937,0,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:PWY-7560,1,0.9643490277966611,0,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7590,1,0.9944661771328446,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.9775463014722509,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.9906435101455832,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-7640,1,0.9963081423084091,0,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-782,1,0.9821121465449147,0,9,glycolipid desaturation,BioCyc
ARA:PWY-7985,1,0.9943474132528771,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.99077095115228,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9950055236482105,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.9978840710853096,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.9942120118871616,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.9706614404120937,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-861,1,0.98283515008654,0,8,dhurrin biosynthesis,BioCyc
ARA:PWY-882,1,0.9513179560984178,0,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-922,1,0.9642608217621709,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9942652721796594,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.9854322935449822,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.9838041255122928,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1313,1,0.9824683930609325,0,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY0-1319,1,0.9762022290497646,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.9890467517577135,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.9811755242090201,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.9956282944166366,0,2,D-serine degradation,BioCyc
ARA:PWY0-162,1,0.9280844500151649,0,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY0-166,1,0.9372735802346606,0,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
ARA:PWY0-461,1,0.986036531501408,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.9831894467696448,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.9931497200824775,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.9853064132981482,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY0A-6303,1,0.9707548569296731,0,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY1F-353,1,0.9943990088827342,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.9926567799830187,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.9909116523928498,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,1,0.9300948067795841,0,33,flavonoid biosynthesis,BioCyc
ARA:PWY3DJ-35471,1,0.9925530073422246,0,4,L-ascorbate biosynthesis IV,BioCyc
ARA:PWY3O-450,1,0.9790145071061468,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.9914616761113402,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-10,1,0.9954678757858998,0,2,scopolin biosynthesis,BioCyc
ARA:PWY4FS-11,1,0.9926742634123645,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-12,1,0.9963265553414267,0,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,1,0.9963265553414267,0,2,extended VTC2 cycle,BioCyc
ARA:PWY4FS-2,1,0.9724575360274168,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.9811343383650484,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.9811343383650484,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.9604961219827638,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.9756677330832364,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.9672770601785992,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY4FS-8,1,0.940026346275403,0,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:PWY66-21,1,0.9390069278712447,0,34,ethanol degradation II,BioCyc
ARA:PWY66-399,1,0.88099952449079,0,62,gluconeogenesis III,BioCyc
ARA:PWY66-423,1,0.9881568075609503,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.9853584199387718,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.9897854392318117,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.9944811183744502,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.9876156074633898,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.9908060355326778,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.9926669076285003,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.9584149355662557,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4449,1,0.9566599495898029,0,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWYQT-4450,1,0.9812118779019513,0,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:PWYQT-4466,1,0.8994354745091296,0,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWYQT-4470,1,0.9928201834429037,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4471,1,0.8726129758331442,0,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:PWYQT-4472,1,0.9430417526784122,0,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,1,0.9430417526784122,0,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,1,0.9430417526784122,0,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWYQT-4475,1,0.9322205621055275,0,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWYQT-4476,1,0.9843625862795489,0,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWYQT-4477,1,0.9642440960301146,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.9031684008245073,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.9831693679996486,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-62,1,0.938549804965849,0,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWYQT-94,1,0.9630362399894284,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.9868186005010906,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:PYRUVDEHYD-PWY,1,0.9555193375911076,0,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:RIBOSYN2-PWY,1,0.9728657003016057,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.9858931848810552,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.9871722859702236,0,6,L-serine biosynthesis,BioCyc
ARA:SUCSYN-PWY,1,0.9222345709517685,0,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:SULFMETII-PWY,1,0.982619886426339,0,9,sulfate reduction II (assimilatory),BioCyc
ARA:THIOREDOX-PWY,1,0.9301616113708246,0,19,thioredoxin pathway,BioCyc
ARA:THRESYN-PWY,1,0.9453198994588229,0,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:TRESYN-PWY,1,0.950585456102019,0,28,trehalose biosynthesis I,BioCyc
ARA:TRIGLSYN-PWY,1,0.8747983765681584,0,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:TRPSYN-PWY,1,0.9590217361270965,0,22,L-tryptophan biosynthesis,BioCyc
ARA:TYRFUMCAT-PWY,1,0.9709765815910343,0,14,L-tyrosine degradation I,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.9765631274280969,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALDEG-PWY,1,0.9418749505638596,0,30,L-valine degradation I,BioCyc
ARA:VALSYN-PWY,1,0.969339764113234,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9926828642198803,0,4,xylose degradation I,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,1.0000000000000004,0.9279828521025547,0,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
